Photo: Tetra Images/Getty Images
Doctronic, which offers access to a free personal AI doctor, announced it raised $40 million in Series B funding.
The round was co-led by Abstract and Lightspeed Venture Partners, with participation from existing investors Seven Stars, Union Square Ventures, Tusk Ventures and Mantis.
Last year, Doctronic secured $20 million in Series A funding and $5 million from Union Square Ventures.
The Series B round brings the company's total raise to $65 million.
WHAT IT DOES
The New York-based company offers a HIPAA-compliant, AI-powered doctor consultation platform accessible 24/7 that autonomously makes clinical decisions. It provides responses to individuals' questions with medical explanations and asks clinical questions in response.
The platform also offers access to licensed physicians via video visits for an insurance copay or for $39 without insurance.
Doctronic will use the funds to expand into pediatrics and generate further partnerships with academic institutions, payers, digital health platforms and hospital systems.
"Health systems see us as infrastructure, the digital front door that routes their patients efficiently and keeps care in-network. Payers see us as unlimited primary care at a predictable cost. This round lets us push further into academic medical centers, digital health platforms, and payers, while continuing to serve millions of consumers directly," Matt Pavelle, co-CEO and cofounder of Doctronic, said in a statement.
MARKET SNAPSHOT
In January, the state of Utah announced a partnership with Doctronic to enable its autonomous AI system to legally renew prescriptions for patients with chronic conditions.
Through the partnership, Doctronic, launched in 2023, became the first AI to legally prescribe routine refills using its autonomous AI platform.
Doctronic said in a statement that it is in talks with regulators and governments in other states to expand its AI prescription services beyond Utah.
Last year, proposed legislation was introduced in the U.S. House of Representatives to allow AI and machine learning technology to prescribe drugs approved by the FDA autonomously.
The Prescription of Drugs by Artificial Intelligence or Machine Learning Technologies, or, if approved, the "Healthy Technology Act of 2025," was sponsored by Rep. David Schweikert, R-Ariz.
If approved, the bill would recognize AI as a "practitioner licensed by law to administer such drugs." The bill was referred to the Committee on Energy and Commerce.
